marijuana

After a red-hot start to 2019, Canadian cannabis producer Aphria Inc (NYSE: APHA) has run out of steam, tumbling more than 31 percent in the past three months. Despite the recent weakness, one Wall Street analyst said Friday that the stock has 30-percent upside potential.  The Analyst...

Terrascend Corp (OTC: TRSSF) reported first-quarter revenue of CA$14.6 million ($10.8 million) Thursday and reiterated its full-year guidance.  What Happened The cannabis company said its revenue surged higher from CA$5 million in the fourth quarter. TerraAscend had zero revenue in the...

Tilray, Inc. (NASDAQ: TLRY) announced Thursday that its wholly owned subsidiary Tilray Portugal Unipessoal Lda. received a standard manufacturing license for its Cantanhede, Portugal-based Biocant Park facility. The facility has earned a Good Manufacturing Practices certification,...

Medicine Man Technologies, Inc. (OTC: MDCL) showed higher revenue and a higher net loss in its first-quarter report Tuesday, and the cannabis company's CEO eyed potential catalysts ahead, including legislation with a direct impact on the Colorado company.  What Happened Medicine Man...

FSD Pharma Inc (OTC: FSDDF), a company engaged in development of medical cannabis and research on cannabinoid-based treatments, announced the addition Monday of three major cannabis researchers to its scientific advisory board. What Happened The Canadian company said Daniel Piomelli, Ph.D...

Multistate cannabis operator Body and Mind Inc (OTC: BMMJ) said Monday that it closed its previously announced private placement offering with M. Partners Inc for 11,780,904 units of the company at a price of CA$1.25 (93 cents) per unit.  The gross proceeds from the offering are CA$14.7...

Cannabis dispensary operator iAnthus Capital Holdings Inc (OTC: ITHUF) unveiled its national retail brand Canaccord Genuity third annual Cannabis Conference: "Be." Why It's Important Stores under the "Be." brand will represent an experience and environment that...

By Susan Ameel, co-founder and partner of Global Regulatory Risk Advisors. The Department of Justice (DOJ) updated its guidance to help prosecutors to evaluate corporate compliance programs.  Prosecutors rely on this guidance when evaluating business organizations during an investigation,...

Canadian cannabis company Tilray Inc (NASDAQ: TLRY) reported first-quarter financial results after the close Tuesday. The company posted an adjusted earnings per share loss of 27 cents, inline with consensus estimates, and sales of $23.04 million. What Happened The company's revenue surged by...

Arizona-based, multistate cannabis company Harvest Health & Recreation Inc (OTC: HRVSF) announced Monday that it closed the first tranche of its brokered private placement for gross proceeds of $100 million. What Happened The company offered unsecured convertible debentures at a price of $1,000...

The SALT Conference is a prestigious gathering of the most well-known executives in finance, policy, economics and beyond. Benzinga headed to Las Vegas to cover them.  Nicholas Vita, vice chairman and CEO of the medical cannabis company Columbia Care, discussed the opioid crisis, the...

MediPharm Labs Corp. (OTC: MEDIF) announced first-quarter financial results Friday. The global extraction, distillation, purification and cannabinoid isolation company generated revenue of $22 million, a 115-percent increase from the fourth quarter of 2018. MediPharm posted a $6.9-million...

Cronos Group Inc (NASDAQ: CRON) said Tuesday that it's expanding its research and development program by opening a facility in Israel that will be focused on cannabinoid devices. What Happened Cronos Device Labs, the company's new R&D facility, is intended to support Cronos...

Canadian cannabis company Terrascend Corp (OTC: TRSSF) is expanding into Europe with the receipt of GMP certification and a new distribution agreement.  What Happened The company said the EU Good Manufacturing Practice certificate was awarded to its Mississauga, Ontario facility in...

Harvard and MIT will receive $4.5 million each for cannabinoid research. The donation comes from the universities' alumnus Charles Broderick, the managing director of Uji Capital, a New York family office with extensive investments in the cannabis industry. What Happened Harvard Medical School...